CLINMARK - CONTRACT RESEARCH AND CONSULTING ORGANIZATION
Katarzyna Dulna has held various positions in the clinical research field, starting as a Clinical Research Associate at Eli Lilly and Company. Katarzyna later worked as a Senior Clinical Research Associate at Pfizer before moving on to CLINMARK where Katarzyna currently serves as the Chief Medical Officer. In their current role, Katarzyna oversees various aspects of clinical development and operations, ensuring clinical trials are conducted in accordance with goals, timelines, and quality standards. Katarzyna also plays a key role in business development and collaboration with internal and external medical experts. Throughout their career, Katarzyna has demonstrated strong leadership, management, and quality assurance skills in the clinical research industry.
This person is not in any teams
CLINMARK - CONTRACT RESEARCH AND CONSULTING ORGANIZATION
Clinmark is a leading Polish Contract Research and Consulting Organization on the Polish market and CEE. Since 2001 we have been organizing, conducting and supervising the management of clinical trials phase I to IV as well as non-interventional studies. With more than 17 600 enrolled patients, 200+ consulting projects, 150+ clinical trials Clinmark team aim at providing global pharma companies, local pharma and biotech companies with reliable and tailored services. 8 out of top 10 worldwide pharmaceutical companies are our clients. Consulting in the area of system management, audit and inspection constitutes the important part of our business. We have participated in the preparation of a number of research centres and headquarters of our partners for FDA, EMA inspections. Clinmark team advise pharmaceutical companies on creating or reorganizing of clinical departments, writing and optimizing internal procedures, creating of compliance departments and, last but not least, selecting subcontractors. For more information about our offer please visit: www.clinmark.pl